Securian Asset Management, Inc Amgen Inc Transaction History

Securian Asset Management, Inc

$3.43 Billion
Q3 2024

A detailed history of Securian Asset Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Securian Asset Management, Inc holds 29,719 shares of AMGN stock, worth $8.75 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

29,719

Previous 30,845 3.65%

Holding current value

$8.75 Million

Previous $9.64 Million 0.64%

% of portfolio

0.28%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $348,361 - $379,889	-1,126 Reduced 3.65%	29,719 $9.58 Million
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $174,991 - $212,660	-666 Reduced 2.11%	30,845 $9.64 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $644,481 - $777,970	-2,397 Reduced 7.07%	31,511 $8.96 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $1.14 Million - $1.29 Million	-4,473 Reduced 11.65%	33,908 $9.77 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $1.39 Million - $1.73 Million	-6,376 Reduced 14.25%	38,381 $10.3 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $119,134 - $140,873	-556 Reduced 1.23%	44,757 $9.94 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $37,255 - $45,408	165 Added 0.37%	45,313 $11 Million
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $179,101 - $227,569	782 Added 1.76%	45,148 $11.9 Million
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $62,624 - $70,628	279 Added 0.63%	44,366 $10 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $622,455 - $692,684	-2,698 Reduced 5.77%	44,087 $10.7 Million
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $113,581 - $125,651	-518 Reduced 1.1%	46,785 $11.3 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $192,316 - $220,089	-967 Reduced 2.0%	47,303 $10.6 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $237,317 - $278,046	-1,118 Reduced 2.26%	48,270 $10.3 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $151,593 - $168,181	-649 Reduced 1.3%	49,388 $12 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $422,738 - $492,633	-1,905 Reduced 3.67%	50,037 $12.5 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $432,327 - $514,824	-1,998 Reduced 3.7%	51,942 $11.9 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $232,303 - $258,340	-990 Reduced 1.8%	53,940 $13.7 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $785,701 - $964,163	-3,972 Reduced 6.74%	54,930 $13 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $185,338 - $245,808	-1,017 Reduced 1.7%	58,902 $11.9 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $450,130 - $578,572	-2,379 Reduced 3.82%	59,919 $14.4 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $249,673 - $299,161	-1,434 Reduced 2.25%	62,298 $12.1 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $147,696 - $173,133	-886 Reduced 1.37%	63,732 $11.7 Million
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $174,720 - $196,948	-966 Reduced 1.47%	64,618 $12.3 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $108,645 - $126,824	-609 Reduced 0.92%	65,584 $12.8 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $337,042 - $379,970	-1,819 Reduced 2.67%	66,193 $13.7 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $3,985 - $4,476	-24 Reduced 0.04%	68,012 $12.6 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $1.02 Million - $1.2 Million	-6,036 Reduced 8.15%	68,036 $11.6 Million
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $22,449 - $25,082	133 Added 0.18%	74,072 $12.9 Million
Q3 2017 Nov 03, 2017	SELL	$167.29 - $191.0 $63,737 - $72,771	-381 Reduced 0.51%	73,939 $13.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	74,320	74,320 $12.8 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Amgen Inc Transaction History